Viewing Study NCT01723020

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-03-03 @ 9:15 PM
Study NCT ID: NCT01723020
Status: COMPLETED
Last Update Posted: 2021-09-02
First Post: 2012-11-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma
Sponsor: Kartos Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Malignancy View
None Advanced Solid Tumors View
None Cancer View
None Oncology View
None Oncology Patients View
None Tumors View
None Glioblastoma View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Solid Tumors View
None Multiple Myeloma View